Legal status · United States
Is Lamivudine legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Lamivudine is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Lamivudine in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| Note | Approved for HIV and hepatitis B. Use for ageing is off label. The label carries warnings about severe acute exacerbations of hepatitis B on discontinuation, which matters because someone taking it for ageing may not know their hepatitis B status. |
| FDA approval status | FDA approved for HIV-1 infection in combination therapy and, as a separate lower-dose product, for chronic hepatitis B. Not approved for ageing, inflammation or neurodegeneration. |
| Human studies cited | 2 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Lamivudine profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Lamivudine for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Lamivudine is
A thirty year old HIV and hepatitis B drug repurposed on the hypothesis that LINE-1 retrotransposons drive the sterile inflammation of ageing. The human ageing evidence is one 12 person open-label pilot in Alzheimer disease with no control group.
Roughly 40 percent of the human genome is retrotransposon sequence. Most of it is silenced, and the silencing appears to fail with age.
Mechanism: A cytidine analogue that is phosphorylated intracellularly to lamivudine triphosphate, which is incorporated by reverse transcriptase and terminates the growing DNA chain because it lacks a 3 prime hydroxyl group. In HIV and hepatitis B that stops viral replication.
Regulatory history: FDA approved for HIV-1 infection in combination therapy and, as a separate lower-dose product, for chronic hepatitis B. Not approved for ageing, inflammation or neurodegeneration.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Lamivudine at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Lamivudine in other countries
Frequently asked questions
Is Lamivudine legal in the United States?
Yes. Lamivudine is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Approved for HIV and hepatitis B. Use for ageing is off label. The label carries warnings about severe acute exacerbations of hepatitis B on discontinuation, which matters because someone taking it for ageing may not know their hepatitis B status.
Can I buy Lamivudine in the United States?
Only with a prescription. Lamivudine is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Approved for HIV and hepatitis B. Use for ageing is off label. The label carries warnings about severe acute exacerbations of hepatitis B on discontinuation, which matters because someone taking it for ageing may not know their hepatitis B status.
Is Lamivudine FDA approved?
Yes. FDA status: FDA approved for HIV-1 infection in combination therapy and, as a separate lower-dose product, for chronic hepatitis B. Not approved for ageing, inflammation or neurodegeneration.. Current US classification: "FDA-approved, prescription only". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Lamivudine live on its compound profile.
Lamivudine profileThis page is general information about the regulatory status of Lamivudine in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.